ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.4400
-0.0200 (-4.35%)
At close: Mar 28, 2025, 4:00 PM
0.4491
+0.0091 (2.07%)
Pre-market: Mar 31, 2025, 4:11 AM EDT

ProPhase Labs Statistics

Total Valuation

ProPhase Labs has a market cap or net worth of $13.30 million. The enterprise value is $42.39 million.

Market Cap 13.30M
Enterprise Value 42.39M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

ProPhase Labs has 30.23 million shares outstanding. The number of shares has increased by 10.53% in one year.

Current Share Class 30.23M
Shares Outstanding 30.23M
Shares Change (YoY) +10.53%
Shares Change (QoQ) +1.01%
Owned by Insiders (%) 11.03%
Owned by Institutions (%) 8.27%
Float 26.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.64
Forward PS 0.17
PB Ratio 0.22
P/TBV Ratio 0.59
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.32
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.78.

Current Ratio 1.47
Quick Ratio 1.12
Debt / Equity 0.78
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.60

Financial Efficiency

Return on equity (ROE) is -58.71% and return on invested capital (ROIC) is -30.95%.

Return on Equity (ROE) -58.71%
Return on Assets (ROA) -24.12%
Return on Invested Capital (ROIC) -30.95%
Return on Capital Employed (ROCE) -56.11%
Revenue Per Employee $112,858
Profits Per Employee -$245,628
Employee Count 113
Asset Turnover 0.14
Inventory Turnover 3.74

Taxes

Income Tax -10.28M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.97% in the last 52 weeks. The beta is -0.51, so ProPhase Labs's price volatility has been lower than the market average.

Beta (5Y) -0.51
52-Week Price Change -92.97%
50-Day Moving Average 0.42
200-Day Moving Average 1.77
Relative Strength Index (RSI) 51.41
Average Volume (20 Days) 1,941,107

Short Selling Information

The latest short interest is 793,412, so 2.62% of the outstanding shares have been sold short.

Short Interest 793,412
Short Previous Month 1.66M
Short % of Shares Out 2.62%
Short % of Float 2.95%
Short Ratio (days to cover) 0.04

Income Statement

In the last 12 months, ProPhase Labs had revenue of $12.75 million and -$27.76 million in losses. Loss per share was -$1.51.

Revenue 12.75M
Gross Profit -4.13M
Operating Income -35.41M
Pretax Income -32.20M
Net Income -27.76M
EBITDA -27.88M
EBIT -35.41M
Loss Per Share -$1.51
Full Income Statement

Balance Sheet

The company has $503,000 in cash and $29.59 million in debt, giving a net cash position of -$29.09 million or -$0.96 per share.

Cash & Cash Equivalents 503,000
Total Debt 29.59M
Net Cash -29.09M
Net Cash Per Share -$0.96
Equity (Book Value) 38.13M
Book Value Per Share 2.00
Working Capital 13.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.18 million and capital expenditures -$2.45 million, giving a free cash flow of -$16.63 million.

Operating Cash Flow -14.18M
Capital Expenditures -2.45M
Free Cash Flow -16.63M
FCF Per Share -$0.55
Full Cash Flow Statement

Margins

Gross margin is -32.38%, with operating and profit margins of -277.69% and -217.64%.

Gross Margin -32.38%
Operating Margin -277.69%
Pretax Margin -298.21%
Profit Margin -217.64%
EBITDA Margin -218.61%
EBIT Margin -277.69%
FCF Margin n/a

Dividends & Yields

ProPhase Labs does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.53%
Shareholder Yield n/a
Earnings Yield -208.70%
FCF Yield -125.05%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 23, 1997. It was a forward split with a ratio of 2:1.

Last Split Date Jan 23, 1997
Split Type Forward
Split Ratio 2:1

Scores

ProPhase Labs has an Altman Z-Score of -0.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.43
Piotroski F-Score 1